NCT06322888
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
At risk: Primary completion moved 12 months later.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 5 versions: 4 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Sep 30, 2026 to Sep 30, 2027 Show 5 more changesShow less
- Eligibility criteria expanded, about 13 words
- Enrollment closed, study ongoing
- Study completion pushed from Dec 31, 2026 to Dec 31, 2027
- Secondary endpoints: details revised at 11 of 14 entries
- Site details revised at 2 of 2 sites
- Notable Primary completion date: Sep 30, 2025 to Sep 30, 2026
- Study completion date: Dec 31, 2025 to Dec 31, 2026
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Mar 2024 to Mar 28, 2024
- Site details revised at 2 of 2 sites
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (14)
Show 9 moreShow less
Arms and interventions
Participants will be randomized and will complete: * Baseline study visit with assessments, breast biopsy, and blood draw. * Exercise program for 12 weeks 3x weekly and exercise logs. Additional blood draw after first exercise session. * End of study visit with assessments, breast biopsy, and blood draw.
Participants will be randomized and will complete: * Baseline study visit with assessments, breast biopsy, and blood draw. * End of study visit with assessments, breast biopsy, and blood draw. * Participants will be offered a complimentary 12-week exercise program after completing the study.
Behavioral: Exercise Training Program
Sites
2 sites in 1 country